Unknown

Dataset Information

0

Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to ?-endorphin?


ABSTRACT: Glycosylated ?-endorphin analogues of various amphipathicity were studied in vitro and in vivo in mice. Opioid binding affinities of the O-linked glycopeptides (mono- or disaccharides) and unglycosylated peptide controls were measured in human receptors expressed in CHO cells. All were pan-agonists, binding to ?-, ?-, or ?-opioid receptors in the low nanomolar range (2.2-35 nM K(i)'s). The glycoside moiety was required for intravenous (i.v.) but not for intracerebroventricular (i.c.v.) activity. Circular dichroism and NMR indicated the degree of helicity in H2O, aqueous trifluoroethanol, or micelles. Glycosylation was essential for activity after i.v. administration. It was possible to manipulate the degree of helicity by the alteration of only two amino acid residues in the helical address region of the ?-endorphin analogues without destroying ?-, ?-, or ?-agonism, but the antinociceptive activity after i.v. administration could not be directly correlated to the degree of helicity in micelles.

SUBMITTER: Li Y 

PROVIDER: S-EPMC3983389 | biostudies-other | 2014 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin?

Li Yingxue Y   St Louis Lindsay L   Knapp Brian I BI   Muthu Dhanasekaran D   Anglin Bobbi B   Giuvelis Denise D   Bidlack Jean M JM   Bilsky Edward J EJ   Polt Robin R  

Journal of medicinal chemistry 20140307 6


Glycosylated β-endorphin analogues of various amphipathicity were studied in vitro and in vivo in mice. Opioid binding affinities of the O-linked glycopeptides (mono- or disaccharides) and unglycosylated peptide controls were measured in human receptors expressed in CHO cells. All were pan-agonists, binding to μ-, δ-, or κ-opioid receptors in the low nanomolar range (2.2-35 nM K(i)'s). The glycoside moiety was required for intravenous (i.v.) but not for intracerebroventricular (i.c.v.) activity.  ...[more]

Similar Datasets

| S-EPMC7547863 | biostudies-literature
| S-EPMC2034331 | biostudies-literature
| S-EPMC3646459 | biostudies-literature
| S-EPMC5961465 | biostudies-literature
| S-EPMC4807253 | biostudies-literature
| S-EPMC7035486 | biostudies-literature
| S-EPMC8684760 | biostudies-literature
| S-EPMC3242435 | biostudies-literature
| S-EPMC10788957 | biostudies-literature
| S-EPMC3552260 | biostudies-literature